Clinical trial
Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines
NCT06104345 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines
- Lead sponsor
- Helsinki University Central Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 25, 2023
- Completion date
- June 26, 2024
- Enrollment
- 65 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.